CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant

PartnershipsemaglutidePositive
AI Analysis

Summary

Novo Nordisk has partnered with Vivani to develop a long-acting semaglutide implant utilizing Vivani's NanoPortal technology for sustained medication delivery.

Importance:6/10
Sentiment:
0.50
partnershipcollaborationdrug deliverysemaglutideimplant technology
Related Companies

Read the original article

Published by Pharmaceutical Technology on July 8, 2026 10:11 AM

Read Original